Pamaylaon, Masilinda V.

HRN: 29-23-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CEFTRIAXONE 1G (VIAL)
07/09/2026
07/16/2026
IV
1 Gram
Q12H
Pathologic Fracture
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines